Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
(αS)-α-methylbenzeneethanamine
Dexamphetamine
(S)-(+)-amphetamine
(+)-(S)-amphetamine
Dextroamphetamine saccharate
Dexamfetamina
(S)-1-phenyl-2-aminopropane
Desamfetamina
(S)-(+)-β-phenylisopropylamine
d-amphetamine
(+)-amphetamine
(+)-α-methylphenylethylamine
Dexamfetamine
Dextroamphetamine adipate
Dexamfetaminum
(S)-α-methylbenzeneethanamine
Dexanfetamina
(S)-amphetamine
(+)-α-methylphenethylamine
Dextroamphetamine sulfate
Dextroamphetamine
(S)-1-phenyl-2-propylamine
Brand Names
ProCentra
PMS-dextroamphetamine
Dexedrine Spansule
Mixed Salts of a Single-Entity Amphetamine Product
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
